AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION: Form 990, tax year 2021

View the entire original 990 at ProPublica ↗

Organization
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION (EIN 23-7033369)
Tax period
2021-06-01 to 2022-05-31
Filed
2023-03-10
IRS object ID
202320699349300622
Schema version
2021v4.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2023-03-10T16:00:18+00:00ReturnTs
Tax Period End2022-05-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN571157523PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1APRIO LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1111 ROCKVILLE PIKE SUITE 600AddressLine1Txt
CityROCKVILLECityNm
State AbbreviationMDStateAbbreviationCd
ZIP20850ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2021-06-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN237033369EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION FDTNBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlAMERBusinessNameControlTxt
Phone3016648612PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line14500 EAST-WEST HIGHWAY 900AddressLine1Txt
CityBethesdaCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20814ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonSTEVEN RUBLOFFPersonNm
Person TitleChief Executive OfficerPersonTitleTxt
Signature2023-03-10SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstSTEVENPersonFirstNm
Person LastRUBLOFFPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonGREGORY M PLOTTS CPAPreparerPersonNm
PTINP01255941PTIN
Phone3012316200PhoneNum
FieldValueIRS element (for citing)
Tax2021TaxYr
Build TS2023-04-26 12:10:37ZBuildTS

Form 990 IRS990

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1ASHP FOUNDATIONBusinessNameLine1Txt

Principal Ofcr Business Name PrincipalOfcrBusinessName

FieldValueIRS element (for citing)
Business Name Line1STEVEN RUBLOFFBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line14500 EAST-WEST HIGHWAY 900AddressLine1Txt
CityBethesdaCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20814ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$3,511,440GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.ashpfoundation.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1968FormationYr
Legal Domicile StateMDLegalDomicileStateCd
Activity Or MissionThe mission of the ASHP Foundation is to support ASHP by advancing the professional practice of pharmacists and the pharmacy workforce by funding research and education that improves health outcomes through optimal, safe and effective medication use.ActivityOrMissionDesc
Voting Members Governing Body15VotingMembersGoverningBodyCnt
Voting Members Independent11VotingMembersIndependentCnt
Total Employee0TotalEmployeeCnt
Total Volunteers100TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$2,768,012PYContributionsGrantsAmt
CY Contributions Grants$1,421,259CYContributionsGrantsAmt
PY Program Service Revenue$1,113,342PYProgramServiceRevenueAmt
CY Program Service Revenue$1,380,758CYProgramServiceRevenueAmt
PY Investment Income$1,032,723PYInvestmentIncomeAmt
CY Investment Income$451,714CYInvestmentIncomeAmt
CY Other Revenue$0CYOtherRevenueAmt
PY Total Revenue$4,914,077PYTotalRevenueAmt
CY Total Revenue$3,253,731CYTotalRevenueAmt
PY Grants And Similar Paid$431,305PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$384,147CYGrantsAndSimilarPaidAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$1,529,410PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$1,650,828CYSalariesCompEmpBnftPaidAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$620,979CYTotalFundraisingExpenseAmt
PY Other Expenses$655,666PYOtherExpensesAmt
CY Other Expenses$712,310CYOtherExpensesAmt
PY Total Expenses$2,616,381PYTotalExpensesAmt
CY Total Expenses$2,747,285CYTotalExpensesAmt
PY Revenues Less Expenses$2,297,696PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$506,446CYRevenuesLessExpensesAmt
Total Assets BOY$13,642,380TotalAssetsBOYAmt
Total Assets EOY$13,385,213TotalAssetsEOYAmt
Total Liabilities BOY$691,055TotalLiabilitiesBOYAmt
Total Liabilities EOY$941,454TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$12,951,325NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$12,443,759NetAssetsOrFundBalancesEOYAmt
MissionOUR MISSION:SUPPORT ASHP BY ADVANCING THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE AND EFFECTIVE MEDICATION USE.OUR VISION:AS THE PHILANTHROPIC ARM OF ASHP, THE FOUNDATION SHARES ASHP'S VISION THAT MEDICATION USE WILL BE OPTIMAL, SAFE, AND EFFECTIVE FOR ALL PEOPLE ALL OF THE TIME.MissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$924,023ExpenseAmt
Grant$131,209GrantAmt
Revenue$714,675RevenueAmt
DescExcellence in Pharmacy Practice & Leadership Development: Recognize and promote efforts that foster excellence and growth of health-system pharmacy. ASHP Student Leadership Awards: This program, funded through the David A. Zilz Fund, is administered by the ASHP Pharmacy Student Forum in collaboration with the ASHP Foundation. Nine students who demonstrate high academic achievement, exceptional interest in health-system pharmacy practice, and outstanding leadership skills were recognized. The awardees received a plaque, a $2,000 award and an ASHP drug information library. Each awardee submitted a plan to raise student awareness of the ASHP Practice Advancement Initiative. Awardees will be surveyed to collect information on implementation and outcomes of their plan. Pharmacy Residency Excellence Awards Program: The 2021 Pharmacy Residency Excellence Awards Program was supported by Amgen, Inc and Samson Medical Technologies. This unique award recognizes excellence and leadership in the training and mentoring of pharmacy residents. The Pharmacy Residency Excellence Awards Program recognizes a preceptor, new preceptor and program. The objectives of this program are to: 1) recognize the achievements of residency programs and pharmacists who have demonstrated excellence and leadership in the training of pharmacy residents and 2) widely disseminate the results of these accomplishments to foster innovations in pharmacy resident training. Each awardee will also present an educational webinar on a resident professional development topic that continuing education credits. The webinars are recorded and made available for on-demand access. Literature Awards Program: The ASHP Foundation Literature Awards program recognizes important contributions to the biomedical literature by pharmacists. This program, administered by the ASHP Foundation since 1971, is based on the concept that recognition through awards stimulates research and innovation and fosters improvement in the quality of the evidence. Awardees are recognized at the ASHP Midyear Clinical Meeting. Pain and Palliative Care Traineeship Program: The Pain and Palliative Care Traineeship included access to the ASHP Pain Management Certificate and live case-based webinars, an experiential training component, and a post-traineeship project component, which was supported through participant tuition in FY20. Due to COVID19, experiential training for all participants was postponed. Four pharmacists completed their experiential training in FY22. Two completed it with The University of Maryland, one completed it at The Johns Hopkins Hospitals and one completed it at The University of Iowa Hospitals and Clinics. Pharmacy Residency Expansion Program: In FY22, the ASHP Foundation, supported by an educational donation from Merck, awarded $75,000 dollars in grants to PGY-1 and PGY-2 pharmacy residency programs to increase the number of available training positions. Pharmacy Student Clinical Skills Competition Program: Lauren Campisi & Yumi Oh, Auburn University Harrison School of Pharmacy competed in a virtual competition for the 2021 ASHP National Clinical Skills CompetitionSM, and were awarded in December 2021, during the ASHP Midyear Clinical Meeting (virtual). The Foundation has sponsored the Pharmacy Student Clinical Skills Competition (CSC) at the ASHP Midyear Clinical Meeting 16 years. Teams who won preliminary competitions at their local pharmacy school participated in the competition. During the CSC, students demonstrate their skills by assessing patient information and current therapy, identifying and prioritizing drug therapy problems, identifying treatment goals, and recommending a pharmacist care plan. Medication Safety Scholars Program: ASHP Foundation in partnership with Emily Jerry Foundation and the ASHP Student Forum selected participants for the Medication Safety Scholars program. The program is a distance impact program structured to support five P2 and P3 Doctor of Pharmacy students, paired with one group coach, to enhance their knowledge and skills in medication safety. Thirty applications were received and reviewed by volunteers from the ASHP Medication Safety Section Advisory Group. Visiting Leaders Program (VLP): The Visiting Leaders program, with support from the David A. Zilz Leaders for the Future Fund, had another successful year. Nine leaders were involved in 25 residency visits, reaching residents, in FY22. Due to COVID-19, there were a mix of onsite and virtual visits. Pharmacy Leadership Academy (PLA): The PLA, supported in part by a grant from Apexis, is an online education program designed to provide comprehensive leadership education to pharmacists and pharmacy technicians. The PLA class in FY22 consisted of 116 participants, who also remitted tuition and were enrolled in the program from July 2021 - June 2022. The number of graduates from this class brings the total number of PLA graduates to 1060 pharmacists. Student Leadership Development Workshop: The 3-hour Leadership Development Workshop for pharmacy students is conducted annually at the ASHP Summer Meetings. State affiliates have taken advantage of the program to engage students at their annual meetings. No workshops were scheduled in FY22. William A. Zellmer Leadership Lecture: Where Practice Meets Policy: This annual luncheon-lecture event, hosted by ASHP in partnership with the ASHP Foundation, is designed to honor the distinguished 40-year ASHP career of William A. Zellmer and is supported by donors to the ASHP Foundation's William Zellmer Fund. Rita Shane was awarded in a virtual ceremony in October 2021, so no travel expenses were incurred or remitted in FY22.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$753,473ExpenseAmt
Grant$252,937GrantAmt
Revenue$0RevenueAmt
DescInnovative Research: Support health services research that foster innovation in pharmacy practice, which promotes the optimal, safe and effective use of medication. Pharmacy Practice Advancement Demonstration Grant (PAI): This grant previously awarded funding up to $75,000 split into three (3) separate payments for demonstration projects related to advancing pharmacy practice and improving outcomes. The grant period for this program is 24 months with the possibility for grantees to request an extension up to one year. Tracking progress reports and final grant payments of previous year's recipients took place in FY22. American Foundation for Pharmaceutical Education (AFPE) Pre-Doctoral Fellowship The ASHP Foundation provided annual funding of $10,000 for the AFPE Pre-Doctoral Fellowship program. Radio Frequency Identification (RFID) Initiative: In alignment with the ASHP Innovation Center and through support from Fresenius Kabi, the ASHP Foundation released the RFID research report, which delved into practice gaps, opportunities and challenges for expanding RFID technology in healthcare. A live webinar to discuss the report was conducted by advisory committee members in Spring 2022 and recorded for on-demand access. An RFID demonstration grant was launched in FY22 - no grantees were recommended for funding from the external review process. Sponsor was notified that no grantees were going to be awarded and approved reopening the program application cycle in FY23. Patient Medication Education: In collaboration with phactMI, the Foundation conducted a survey of ASHP members to understand the role, systems and processes, resource needs related to medication education to optimize patient care and outcomes. PhactMI conducted a survey to the public to understand patient education needs and preferences. Results were highlighted in a 2021 ASHP Midyear educational session. A manuscript of all results is still in development. Pharmacy Leadership Scholars: The ASHP Foundation launched a new research grant program with corporate support from Chiesi. The Pharmacy Leadership Scholars program is a research grant program providing funding for projects focused on DEI conducted by early-stage pharmacists. In addition to providing up to $10,000 in grant funding per recipient, the program's goal is to enhance the leadership and research skills of recipients and to provide a network of pharmacists positioned to lead for equity. The selected participants participated in an online impact collaborative consisting of four education modules with a focus on leadership development and DEI. Fifteen proposals were received and advanced for review by an external panel in FY21 and five grants were awarded in FY22. Collaborative Care Grant for Nurses and Pharmacists: Created in partnership by the ASHP Foundation and the American Nurses Foundation, this grant program aims to stimulate patient-centered interprofessional health services research that demonstrates meaningful outcomes. The application launched in FY21 in order to select recipients of research grant funding up to $75,000. Fifteen proposals were received and advanced for review by an external pane and one research team was awarded in FY22. Biosimilars Project: In collaboration with ASHP, the Foundation initiated a research project to explore the opportunities and barriers related to implementing biosimilars in practice. Amgen sponsored the project providing $126,800 to the Foundation, of which $58,800 was budgeted for the research and report to be conducted by the Foundation and $68,000 was budgeted for the dissemination activities to be done by ASHP under the Advantage brand. The Foundation convened an advisory panel of experts, including pharmacists, a physician and payer representation and engaged an interprofessional research panel in virtual qualitative research using the Canvas system. The work of the virtual research panel was completed in FY22 and the advisory panel began creating the report of the findings that was completed in summer, FY23. MUE Project: Development of a medication-use evaluation (MUE) template for andexanet alfa in the reversal of anticoagulation with factor Xa inhibitors: The Foundation initiated a project to create an MUE template for andexanet. The project was funded by Alexion for $95,900. The Foundation engaged a contractor and a medical writer and then convened content matter experts to develop the MUE template using the newly published AJHP MUE guidelines. The deliverables of the project included: the MUE template with implementation strategies and a manuscript to be submitted to AJHP for first right of refusal. Work on the deliverables was not completed in FY22 and continued into FY23, as planned. Specialty Pharmacy Grant: Planning for a new grant to be administered by the Foundation in close consultation with the ASHP Section of Specialty Pharmacy Practitioners was initiated with a survey to registrants of the ASHP Specialty Pharmacy Conference held virtually, July 14-16 2021. Results and input from ASHP and other key stakeholders led to the creation of a grant program focused on specialty pharmacy services for patients being treated for rheumatoid arthritis. The program was designed to be a grant plus cohort engagement with elevated visibility for the grantees to present their results at an ASHP national meeting. Funding for the grant program was ear-marked from excess funds raised by the Foundation to support the ASHP Specialty Pharmacy Summit held in FY21. The grant program was approved the Foundation Board of Directors and opened for submissions January - March, 2021. Five grantees were approved for funding of $5,000 each, in May, 2022. Pharmacy Resident Practice-Based Research Grant Program: This grant program is funded through the ASHP member dues contribution to the Foundation. A six-member external peer review panel recommended awarding 8 grants up to $5,000. One grant was declined because IRB could not be received in time. Funding is distributed upon receipt of IRB-approval, resulting in distribution of grant funds for only 7 recipients in FY22. New Practitioner Pharmacist Leadership Development Research Grant Program: Funded through the Marianne F. Ivey Leadership Development Fund, awards New Practitioner Pharmacists to support research on leadership competency development or to create education, resources and tools to support leadership development. Grant recipients were selected in FY21 for grants up to $5,000 each. Funding is distributed upon receipt of IRB-approval, resulting in distribution of grant funds in FY21 and FY22. Grantees also participated in a virtual Impact Collaborative, consisting of modules that provide educational content and the opportunity to discuss the progress of their projects. The 2021-2022 application cycle was not opened in FY22. Optimizing Technology Solutions Innovation Grant: Seventeen full applications were reviewed by an external panel in order to distribute funding to grantees in FY22. Created in partnership with the ASHP Innovation Center and supported by a generous donation from Omnicell to the ASHP Foundation, each grantee was awarded up to $30,000. Research Advisory Council: In FY22, ASHP Foundation Board of Directors reappointed five members to the Research Advisory Council (RAC) and appointed to seven new members following an open call. The RAC convened in-person in April and virtually throughout the year to review and update the research agenda framework of Core Principles and Priority Research Areas that align with the Foundation's mission and ASHP's major priorities and are at the forefront of the national healthcare agenda. In addition they identified and prioritized ideas to raise awareness of researcher careers and support researcher development. New activities were planned for FY23. Pharmacy Forecast Report 2022: The 2022 Pharmacy Forecast Report was supported by a grant from Omnicell, Inc., to the ASHP Foundation's David A. Zilz Leaders for the Future Fund and was published in AJHP in the January 15, 2022 issue. The distribution of the Forecast Report in AJHP ensured that it was made available to all 60,000 ASHP members. It was published electronically in December 2021 and previewed during an educational session at the 2021 ASHP Midyear Clinical Meeting. The report generated authoritative, actionable strategic recommendations to enhance the effectiveness of leaders in hospital and health-system pharmacy.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$0ExpenseAmt
Grant$0GrantAmt
Revenue$641,083RevenueAmt
DescTHE ASHP FOUNDATION CORPORATE PARTNERS PROGRAM IS A STRATEGIC PARTNERSHIP BETWEEN THE ASHP FOUNDATION, ASHP, AND CORPORATIONS WHICH PROMOTES MEDICATION SAFETY AND IMPROVEMENTS IN PATIENT CARE. THE PROGRAM OFFERS A ROBUST MENU OF SPONSORSHIP LEVELS AND BENEFITS FOR COMPANIES, FOCUSED ON COLLABORATION, RECOGNITION, AND INFORMATIONAL OPPORTUNITIES. THERE ARE FOUR SPONSORSHIP LEVELS AND A-LA-CARTE OPPORTUNITIES TO BETTER MEET BUSINESS OBJECTIVES. CORPORATE PARTNERS PROGRAM SPONSORSHIP IS ON AN ANNUAL BASIS. WITH THE GENEROUS SUPPORT OF CORPORATE PARTNERS, THE ASHP FOUNDATION INVESTS IN RESEARCH, AWARDS, EDUCATION, AND LEADERSHIP DEVELOPMENT THAT ADVANCES THE PHARMACY PROFESSION AND ENSURES THE SAFE, EFFECTIVE, AND OPTIMAL USE OF MEDICATIONS.Desc
FieldValueIRS element (for citing)
Total Program Service Expenses$1,677,496TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesfalseLobbyingActivitiesInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (true)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesfalseReportOtherLiabilitiesInd
Include FIN48 FootnotefalseIncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (true)IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (true)ConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesfalseForeignActivitiesInd
More Than5000 K To OrgfalseMoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingfalseProfessionalFundraisingInd
Fundraising ActivitiesfalseFundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsYes (true)GrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With35 Ctrl EntfalseBusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityYes (true)RelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgYes (true)TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document72IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee0EmployeeCnt
Unrelated Bus Incm Over LimitfalseUnrelatedBusIncmOverLimitInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsfalseQuidProQuoContributionsInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtfalseSubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst IncfalseSubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members15GoverningBodyVotingMembersCnt
Independent Voting Member11IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersYes (true)ElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesfalseMinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherfalseCompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1Tracy YaklyvichBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone3016648696PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line14500 EAST-WEST HIGHWAY SUITE 900AddressLine1Txt
CityBethesdaCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20814ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (18 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtHighest Compensated EmployeeHighestCompensatedEmployeeInd
Christene Jolowsky
Treasurer1.04.0Yes (X)Yes (X)$0$0$0
John T Tighe III
Chair1.00.0Yes (X)Yes (X)$0$0$0
Kelly M Smith
Vice Chair1.00.0Yes (X)Yes (X)$0$0$0
Paul W Abramowitz
President3.040.0Yes (X)Yes (X)$0$1,053,996$61,893
Steven A Rubloff
Secretary and CEO40.00.0Yes (X)Yes (X)$367,116$0$69,787
Chris Hatwig
Director At Large1.00.0Yes (X)$0$0$0
Ellen Wetterling
Director At Large1.00.0Yes (X)$0$0$0
Janet Mighty
Director At Large1.00.0Yes (X)$0$0$0
Ken Perez
Director At Large1.00.0Yes (X)$0$0$0
Linda Tyler
ASHP President1.05.0Yes (X)$0$10,000$0
Lindsey Thomas
Director At Large1.00.0Yes (X)$0$0$0
Roger Anderson
Director At Large1.00.0Yes (X)$0$0$0
Scott M Samson
Director At Large1.00.0Yes (X)$0$0$0
Thomas J Johnson
ASHP Immediate Past President1.00.0Yes (X)$0$10,000$0
Thomas J Rice
Director At Large1.00.0Yes (X)$0$0$0
Barbara Nussbaum
VP, Research and Education40.00.0$191,947$0$57,796Yes (X)
Martha Crews
VP, Development40.00.0$134,752$0$41,770Yes (X)
Stephanie Brown
Director, Operations40.00.0$125,825$0$25,420Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$819,640TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$1,073,996TotReportableCompRltdOrgAmt
Total Other Compensation$256,666TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K4IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd
Cntrct Rcvd Greater Than100 K0CntrctRcvdGreaterThan100KCnt
Related Organizations$363,500RelatedOrganizationsAmt
All Other Contributions$1,057,759AllOtherContributionsAmt
Noncash Contributions$109,448NoncashContributionsAmt
Total Contributions$1,421,259TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (4 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtExclusionExclusionAmt
PHARMACY LEADERSHIP ACADEMY611430$704,675$704,675
CORPORATE PARTNER PROGRAM611430$641,083$641,083
SPONSORSHIPS900099$25,000$25,000
PAIN & PALLIATIVE TRAINING611430$10,000$10,000

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$1,380,758TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$446,440TotalRevenueColumnAmt
Exclusion$446,440ExclusionAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$262,983SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$257,709SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$5,274SecuritiesAmt
Other$0OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$5,274TotalRevenueColumnAmt
Exclusion$5,274ExclusionAmt

Miscellaneous Revenue MiscellaneousRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$0OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$3,253,731TotalRevenueColumnAmt
Related Or Exempt Func Income$1,355,758RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$476,714ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$341,647TotalAmt
Program Services$341,647ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$42,500TotalAmt
Program Services$42,500ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$436,903TotalAmt
Program Services$185,398ProgramServicesAmt
Management And General$92,324ManagementAndGeneralAmt
Fundraising$159,181FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$965,489TotalAmt
Program Services$409,700ProgramServicesAmt
Management And General$204,023ManagementAndGeneralAmt
Fundraising$351,766FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$71,291TotalAmt
Program Services$30,252ProgramServicesAmt
Management And General$15,064ManagementAndGeneralAmt
Fundraising$25,975FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$100,177TotalAmt
Program Services$42,510ProgramServicesAmt
Management And General$21,169ManagementAndGeneralAmt
Fundraising$36,498FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$76,968TotalAmt
Program Services$32,661ProgramServicesAmt
Management And General$16,264ManagementAndGeneralAmt
Fundraising$28,043FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$13,135TotalAmt
Management And General$13,135ManagementAndGeneralAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$58,838TotalAmt
Management And General$58,838ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$473,405TotalAmt
Program Services$464,278ProgramServicesAmt
Management And General$255ManagementAndGeneralAmt
Fundraising$8,872FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$69,867TotalAmt
Program Services$58,619ProgramServicesAmt
Management And General$4,347ManagementAndGeneralAmt
Fundraising$6,901FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$300TotalAmt
Management And General$300ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$37,098TotalAmt
Program Services$25,280ProgramServicesAmt
Management And General$8,075ManagementAndGeneralAmt
Fundraising$3,743FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$42,151TotalAmt
Program Services$42,151ProgramServicesAmt

Other Expenses OtherExpensesGrp (2 entries)

DescDescTotalTotalAmtManagement And GeneralManagementAndGeneralAmtProgram ServicesProgramServicesAmt
credit card fees$15,016$15,016
Honoraria$2,500$2,500

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$2,747,285TotalAmt
Program Services$1,677,496ProgramServicesAmt
Management And General$448,810ManagementAndGeneralAmt
Fundraising$620,979FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$264,584BOYAmt
EOY$506,045EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$460,822BOYAmt
EOY$547,495EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$1,318,997BOYAmt
EOY$1,390,682EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$72,917BOYAmt
EOY$74,420EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$68,366BOYAmt
EOY$62,661EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$283,347LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$183,665LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$141,833BOYAmt
EOY$99,682EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$11,144,108BOYAmt
EOY$10,540,167EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$147,234BOYAmt
EOY$115,405EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$23,519BOYAmt
EOY$48,656EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$13,642,380BOYAmt
EOY$13,385,213EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$180,805BOYAmt
EOY$177,452EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$510,250BOYAmt
EOY$764,002EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$691,055BOYAmt
EOY$941,454EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$3,192,823BOYAmt
EOY$3,083,557EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$9,758,502BOYAmt
EOY$9,360,202EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$12,951,325BOYAmt
EOY$12,443,759EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$13,642,380BOYAmt
EOY$13,385,213EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$506,446ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$1,014,012NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consol And Sep Basis Fincl StmtYes (X)ConsolAndSepBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredfalseFederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$2,088,349CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,768,602CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$928,082CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$2,768,012CurrentTaxYearMinus1YearAmt
Current Tax Year$1,421,259CurrentTaxYearAmt
Total$8,974,304TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$2,088,349CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,768,602CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$928,082CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$2,768,012CurrentTaxYearMinus1YearAmt
Current Tax Year$1,421,259CurrentTaxYearAmt
Total$8,974,304TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$4,380,763SubstantialContributorsTotAmt
Public Support Total170$4,593,541PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$315,175CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$406,338CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$303,024CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$338,642CurrentTaxYearMinus1YearAmt
Current Tax Year$446,440CurrentTaxYearAmt
Total$1,809,619TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$0CurrentTaxYearMinus1YearAmt
Current Tax Year$0CurrentTaxYearAmt
Total$0TotalAmt
FieldValueIRS element (for citing)
Total Support$10,783,923TotalSupportAmt
Gross Receipts Rltd Activities$4,778,592GrossReceiptsRltdActivitiesAmt
Public Support CY1700.4260PublicSupportCY170Pct
Public Support PY1700.4449PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$7,675,259BeginningYearBalanceAmt
Contributions$23,200ContributionsAmt
Investment Earnings Or Losses-$221,586InvestmentEarningsOrLossesAmt
Other Expenditures$192,096OtherExpendituresAmt
End Year Balance$7,284,777EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$6,731,177BeginningYearBalanceAmt
Contributions$2,650ContributionsAmt
Investment Earnings Or Losses$2,218,348InvestmentEarningsOrLossesAmt
Other Expenditures$1,276,916OtherExpendituresAmt
End Year Balance$7,675,259EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$6,808,429BeginningYearBalanceAmt
Contributions$1,300ContributionsAmt
Investment Earnings Or Losses$106,680InvestmentEarningsOrLossesAmt
Other Expenditures$185,232OtherExpendituresAmt
End Year Balance$6,731,177EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$6,838,821BeginningYearBalanceAmt
Contributions$1,480ContributionsAmt
Investment Earnings Or Losses$93,478InvestmentEarningsOrLossesAmt
Other Expenditures$125,350OtherExpendituresAmt
End Year Balance$6,808,429EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$6,732,965BeginningYearBalanceAmt
Contributions$6,019ContributionsAmt
Investment Earnings Or Losses$423,554InvestmentEarningsOrLossesAmt
Other Expenditures$323,717OtherExpendituresAmt
End Year Balance$6,838,821EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.0691BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.7022PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.2287TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgfalseEndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$83,984OtherCostOrOtherBasisAmt
Depreciation$83,984DepreciationAmt
Book Value$0BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$199,363OtherCostOrOtherBasisAmt
Depreciation$99,681DepreciationAmt
Book Value$99,682BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$99,682TotalBookValueLandBuildingsAmt
Total Rev Etc Audited Fincl Stmt$2,458,714TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$1,014,012NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$277,833DonatedServicesAndUseFcltsAmt
Other Revenue$0OtherRevenueAmt
Revenue Not Reported-$736,179RevenueNotReportedAmt
Revenue Subtotal$3,194,893RevenueSubtotalAmt
Investment Expenses Not Incld$58,838InvestmentExpensesNotIncldAmt
Other Revenues Not Included$0OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$58,838RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$3,253,731TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$2,966,280TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$277,833DonatedServicesUseFcltsAmt
Other Expenses Included$0OtherExpensesIncludedAmt
Expenses Not Reported$277,833ExpensesNotReportedAmt
Expenses Subtotal$2,688,447ExpensesSubtotalAmt
Investment Expenses Not Incld2$58,838InvestmentExpensesNotIncld2Amt
Other Expenses Not Included$0OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$58,838ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$2,747,285TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule D, Part V, Line 4 Intended uses of endowment fundsFormAndLineReferenceDesc
ExplanationTHE FOUNDATION'S ENDOWMENT PRIMARILY CONSISTS OF CONTRIBUTIONS TO THE JOSEPH A. ODDIS ENDOWMENT CAMPAIGN, THE PURPOSE OF WHICH IS TO RAISE FUNDS FOR PROGRAMS THAT IMPROVE PHARMACY PRACTICE AND THE SAFE AND EFFECTIVE USE OF MEDICATIONS.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (13 entries)

Address Line1USAddress/AddressLine1TxtAddress Line2USAddress/AddressLine2TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION
11325 RANDOM HILLS ROAdSUITE 360-A105FAIRFAXVA22030530214882501(C)(3)$10,000THE PURPOSE OF THE GRANT WAS 2021 SPONSORSHIP
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
4500 EAST-WEST HIGHWAY SUITE 900SUITE 900BETHESDAMD20814520807628501(C)(6)$15,800CLINICAL SKILL COMPETITION GRANT
FLORIDA A&M UNIVERSITY
FOOTE HILYER ADMIN CENTER1700 LEE HALL DRIVE ROOM 201TALLAHASSEEFL32307590977035STATE UNIVERSITY$25,500PRACTICE ADVANCE GRANT ASSISTANT
H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC
12902 MAGNOLIA DRIVETAMPAFL33612592451713501(C)(3)$23,600PRACTICE ADVANCEMENT GRANT & GRANT REFUND
LEHIGH VALLEY HEALTH NETWORK
2100 MACK BOULEVARDALLENTOWNPA181035622231689692501(C)(3)$25,000RESIDENT EXPANSION GRANT ASSISTANT
NORTHERN CALIFORNIA HEALTH SERVICES & RESEARCH FOUNDATION
5150 FAIR OAKS BOULEVARD101-285CARMICHAELCA95608215731085501(C)(3)$10,000PHARMACY LEADERSHIP SCHOLARS GRANT
STATE OF MISSISSIPPI UNIVERSITY OF MISSISSIPPI MEDICAL CENTER
2500 NORTH STATE STREETJACKSONMS392164505646008520501(C)(3)$25,000RESIDENT EXPANSION GRANT ASSISTANT
TEXAS SOUTHERN UNIVERSITY
3100 CLEBURNE STREETHOUSTONTX770044598746001391STATE UNIVERSITY$10,000PHARMACY LEADERSHIP SCHOLARS GRANT
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
UC DAVIS MEDICAL CENTER4800 2ND AVENUE 3010SACRAMENTOCA95817946036494GOVERNMENT$35,000Resident Expansion Grant & Pharmacy Leadership Scholars Grant
UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC
310 EAST CAMPUS ROADATHENSGA30602581353149501(C)(3)$30,000Optimizing Technology Innovation Grant
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
PO BOX 402420ATLANTAGA303842420566001393501(C)(3)$22,479New Practitioner Grant, Pharmacy Leadership Scholars Grant & 2021 Residency Grant
UNIVERSITY OF PITTSBURGH
500 ROSS STREETSUITE 154-0455PITTSBURGHPA152620001250965591501(C)(3)$47,339American Nurses Foundation Grant & Pharmacy Leadership Scholars Grant
UNIVERSITY OF PUERTO RICO - MED SCIENCES
PO BOX 365067SAN JUANPR009365067660433762STATE INSTITUTION$30,000Optimizing Technology Innovation Grant
FieldValueIRS element (for citing)
Total501c3 Org12Total501c3OrgCnt
Total Other Org1TotalOtherOrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (2 entries)

Grant TypeGrantTypeTxtRecipientRecipientCntCash GrantCashGrantAmt
Literature Awards5$18,500
Student Leadership Awards12$24,000

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule I, Part I, Line 2 Procedures for monitoring use of grant funds.FormAndLineReferenceDesc
ExplanationTHE ASHP FOUNDATION HAS A DETAILED REPORTING REQUIREMENT FOR ALL GRANTS AWARDED, WHICH INCLUDES REPORTING PROGRESS AT 6-MONTH INTERVALS. THE ASHP FOUNDATION HAS A GOOD TRACK RECORD OF ENSURING STUDY COMPLETION AND PUBLICATION OF STUDY RESULTS.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanfalseSupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgYes (true)CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsYes (true)CompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (true)AnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (5 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Steven A Rubloff
Secretary and CEO$339,794$0$25,000$0$2,322$0$28,700$0$41,087$0$436,903$0$0$0
Paul W Abramowitz
President$0$852,052$0$177,500$0$24,444$0$28,700$0$33,193$0$1,115,889$0$0
Barbara Nussbaum
VP, Research and Education$181,922$0$8,254$0$1,771$0$19,416$0$38,380$0$249,743$0$0$0
Martha Crews
VP, Development$128,314$0$5,801$0$637$0$9,714$0$32,056$0$176,522$0$0$0
Stephanie Brown
Director, Operations$120,462$0$5,152$0$211$0$12,101$0$13,319$0$151,245$0$0$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule J, Part I, Line 6a Compensation contingent on net earnings of the organizationPAUL ABRAMOWITZ, PRESIDENT/ASHP CEO, AND STEVEN RUBLOFF, SECRETARY/ASHP REF CEO, RECEIVE A BONUS BASED ON THE ACHIEVEMENT OF SPECIFIC FINANCIAL AND NON-FINANCIAL OUTCOMES FOR THEIR RESPECTIVE ORGANIZATIONS.
Schedule J, Part I, Line 6b Compensation contingent on net earnings of a related organizationPAUL ABRAMOWITZ, PRESIDENT/ASHP CEO, AND STEVEN RUBLOFF, Chief Executive Officer, RECEIVE A BONUS BASED ON THE ACHIEVEMENT OF SPECIFIC FINANCIAL AND NON-FINANCIAL OUTCOMES FOR THEIR RESPECTIVE ORGANIZATIONS.
Schedule J, Part I, Line 7 Non-fixed paymentsALL ASHP-REF EMPLOYEES ARE ELIGIBLE FOR AN ANNUAL PERFORMANCE INCENTIVE PROGRAM IN ACCORDANCE WITH POLICY, AT THE DISCRETION OF THE BOARD OF DIRECTORS, BASED ON MUTUALLY AGREED UPON PREDETERMINED OBJECTIVES.

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution1873ContributionCnt
Noncash Contributions Rpt F990$109,448NoncashContributionsRptF990Amt
Method Of Determining RevenuesMarket valueMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Form8283 Received0Form8283ReceivedCnt
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsfalseReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule M, Part I Explanations of reporting method for number of contributionsFormAndLineReferenceDesc
ExplanationSecurities - Publicly traded - The number reported in column (b) represents the number of shares received.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (7 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Form 990, Part VI, Line 7a Members or stockholders electing members of governing bodyTHREE MANDATORY MEMBERS OF THE FOUNDATION'S BOARD OF DIRECTORS ARE: THE IMMEDIATE PAST PRESIDENT, CEO, AND TREASURER OF THE AMERICAN SOCIETY OF HEALTHSYSTEM PHARMACISTS, A RELATED 501(C)(6) MEMBERSHIP ORGANIZATION. THE AFOREMENTIONED TREASURER AND CEO SHALL SERVE, RESPECTIVELY, AS THE TREASURER AND PRESIDENT OF THE FOUNDATION, AND THE IMMEDIATE PAST PRESIDENT SHALL SERVE AS A DIRECTOR OF THE FOUNDATION. THE BOARD OF DIRECTORS OF THE AMERICAN SOCIETY OF HEALTHSYSTEM PHARMACISTS MAY ALSO APPOINT ONE OR MORE MEMBERS OF THE PUBLIC TO SERVE AS MEMBERS OF THE FOUNDATION'S BOARD.
Form 990, Part VI, Line 8b Documentation of meetings held by committees of governing bodyTHERE ARE NO COMMITTEES THAT HAVE THE AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY.
Form 990, Part VI, Line 11b Review of form 990 by governing bodyThe Form 990 is reviewed by officers of ASHP and ASHP Foundation and by the Board before it is filed. Each member has the opportunity to review the Form 990.
Form 990, Part VI, Line 12c Conflict of interest policyTHE CONFLICT OF INTEREST POLICY WILL BE REVIEWED ANNUALLY AT THE SPRING OR FALL MEETING.
Form 990, Part VI, Line 15a Process to establish compensation of top management officialCHIEF EXECUTIVE OFFICER: PURSUANT TO THE BYLAWS, THE BOARD OF DIRECTORS HAS THE RESPONSIBILITY FOR THE SELECTION AND HIRING OF THE CEO OF THE ORGANIZATION. ELEVEN MEMBERS OF THE BOARD ARE CONSIDERED INDEPENDENT PERSONS AND RECEIVE NO COMPENSATION FROM THE ORGANIZATION. THE BOARD REVIEWS SALARY SURVEY DATA REPORTS FOR OTHER COMPARABLE EXEMPT ORGANIZATIONS AS WELL AS DATA FOR POSITIONS WHICH HAVE SIMILAR RESPONSIBILITIES. OTHER EMPLOYEES WHO ARE EMPLOYED BY THE ORGANIZATION ARE "EMPLOYEES AT WILL". SALARIES FOR THESE INDIVIDUALS ARE DETERMINED USING RELEVANT COMPARABLE SALARY DATA. PRIOR TO FILLING A VACANT POSITION, A HIRING SUPERVISOR, IN CONJUNCTION WITH THE HUMAN RESOURCES DIVISION, RESEARCHES RELEVANT SALARY RANGES FOR THE POSITION.
Form 990, Part VI, Line 19 Required documents available to the publicTHE FOUNDATION'S FINANCIAL STATEMENTS, GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST.
Form 990, Part IX, Line 11g Other FeesCONTRACT SERVICES - Total Expense: 473405, Program Service Expense: 464278, Management and General Expenses: 255, Fundraising Expenses: 8872;

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS (ASHP)BusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line14500 EAST-WEST HIGHWAYAddressLine1Txt
Address Line2SUITE 900AddressLine2Txt
CityBETHESDACityNm
State AbbreviationMDStateAbbreviationCd
ZIP20814ZIPCd
FieldValueIRS element (for citing)
EIN520807628EIN
Primary ActivitiesTO ADVANCE PUBLIC HEALTH BY SUPPORTING THE PHARMACY PROFESSIONPrimaryActivitiesTxt
Legal Domicile StateMDLegalDomicileStateCd
Exempt Code Section501(c)(6)ExemptCodeSectionTxt

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1NABusinessNameLine1Txt
FieldValueIRS element (for citing)
Controlled OrganizationfalseControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts RyltsfalseReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgYes (true)GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgYes (true)GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other OrgfalseLoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth OrgfalseLoansOrGuaranteesFromOthOrgInd
Div Related OrganizationfalseDivRelatedOrganizationInd
Asset Sale To Other OrgfalseAssetSaleToOtherOrgInd
Asset Purchase From Other OrgfalseAssetPurchaseFromOtherOrgInd
Asset ExchangefalseAssetExchangeInd
Rental Of Facilities To Oth OrgfalseRentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth OrgfalseRentalOfFcltsFromOthOrgInd
Perform Of Services For Oth OrgfalsePerformOfServicesForOthOrgInd
Perform Of Services By Other OrgfalsePerformOfServicesByOtherOrgInd
Sharing Of FacilitiesYes (true)SharingOfFacilitiesInd
Paid Employees SharingYes (true)PaidEmployeesSharingInd
Reimbursement Paid To Other OrgYes (true)ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgfalseReimbursementPaidByOtherOrgInd
Transfer To Other OrgfalseTransferToOtherOrgInd
Transfer From Other OrgYes (true)TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (6 entries)

Transaction TypeTransactionTypeTxtInvolvedInvolvedAmtMethod Of Amount DeterminationMethodOfAmountDeterminationTxt
American Society of Health-System Pharmacists
P$1,697,763Recorded expenses
American Society of Health-System Pharmacists
S$1,058,363Cash
American Society of Health-System Pharmacists
N$639,400Recorded expenses
American Society of Health-System Pharmacists
C$363,500Cash
American Society of Health-System Pharmacists
O$180,698Fair Value
American Society of Health-System Pharmacists
B$15,800Cash

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.